NPS PHARMACEUTICALS (NASDAQ:NPSP)
3.08
0.01 (0.32%)
| NPS PHARMACEUTICALS (NASDAQ:NPSP) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $3.09 | 52 Week High | $7.00 | ||
| Open | $3.05 | 52 Week Low | $2.74 | ||
| Day High | $3.10 | P/E | N/A | ||
| Day Low | $3.00 | EPS | $-0.51 | ||
| Volume | 261,626 | ||||
| More NPSP Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| TIN | 2 | UNH | 2 |
| SNTA | 2 | CPST | 2 |
| ESLR | 2 | HGSI | 2 |
| JAZZ | 2 | MBRX | 2 |
| STAA | 2 | APSG | 1 |
| PNFP | 1 | ARII | 1 |
Entities who have mentioned NPSP
- Brean Murray Carret & Co. | View Related Stories »
- Goldman Sachs | View Related Stories »
- Citi | View Related Stories »
- Jefferies & Co | View Related Stories »
- Piper Jaffray | View Related Stories »
- Crude Oil | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- UBS | View Related Stories »
- Trading Radar | View Related Stories »
- Layoffs | View Related Stories »
- Vanguard | View Related Stories »
- GLG Partners | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Canaccord Adams | View Related Stories »
- Lazard | View Related Stories »
- Standard & Poor's | View Related Stories »
- Dividend | View Related Stories »
- Keefe, Bruyette & Woods | View Related Stories »
- Morgan Stanley | View Related Stories »
- Banc of America | View Related Stories »
- Morgan Joseph | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- ADP Employment Report | View Related Stories »
- Federal Open Market Committee | View Related Stories »
View All ReportsStreetInsider.com Reports on NPSP
- NPS Pharma (NPSP) Reports Q3 Loss of $0.16, Misses by 4c
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- NPS PHARMACEUTICALS (NPSP) Moving Higher After Reporting Strong Earnings
- Notable Analyst Rating Changes 6/11: RF, FITB, BBT, HBAN, STI, BAC, GSK Upgraded; UNH, TIN, ALV, VPRT Downgraded
- Morning Movers 6/11: STAA, CPST, HGSI, CHDX, MBRX, OBCI Higher; LULU, UNH, LUB, LTON, PNFP Lower
View All Press ReleasesCompany Press Releases on NPSP
- NPS Pharmaceuticals Reports Third Quarter Results and Improved Cash Burn Guidance
- NPS Pharmaceuticals to Report Third Quarter Financial Results on November 4, 2009
- Data Demonstrate That GATTEX(TM) (Teduglutide) Improves Lean Body Mass, Mineral Composition and Electrolyte Levels in Patients with Parenteral Nutrition Dependent Short Bowel Syndrome
- NPS Reports Two Teduglutide Abstracts Accepted for Presentation at American College of Gastroenterology Annual Scientific Meeting
StreetInsider Reports on NPSP by Category
View All BlogsBlogs on NPSP
- Our Monthly Buy / Sell List
- Seven New Extreme Biotech Trades
- 20 Stocks Which May Be Threatening Your Portfolio
- 20 Stocks to Avoid from Russell 2000
- NPS Pharmaceuticals Inc. Q4 2008 Earnings Call Transcript
View All FilingsSEC Filings on NPSP
- Form 10-Q NPS PHARMACEUTICALS INC For: Sep 30
- Form 8-K NPS PHARMACEUTICALS INC For: Nov 04
- Form 4 NPS PHARMACEUTICALS INC For: Oct 19 Filed by: STRATEMEIER ED
- Form 4 NPS PHARMACEUTICALS INC For: Oct 15 Filed by: KUHLA DONALD E
- Form 4 NPS PHARMACEUTICALS INC For: Oct 15 Filed by: TOMBROS PETER G
Comments on NPSP
No comments are currently available.
